Detalhe da pesquisa
1.
Dersimelagon in Erythropoietic Protoporphyrias.
N Engl J Med
; 388(15): 1376-1385, 2023 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37043653
2.
Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
N Engl J Med
; 388(24): 2241-2252, 2023 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37256972
3.
Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis: a randomized controlled observer-blind pragmatic trial (ABC trial).
Br J Dermatol
; 190(3): 342-354, 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37936331
4.
Guidelines of care for the management of acne vulgaris.
J Am Acad Dermatol
; 90(5): 1006.e1-1006.e30, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38300170
5.
Genetic Polymorphisms of rs9949644 in MAPK4 Are Associated with Clinical Response to Methotrexate in Patients with Psoriasis.
Dermatology
; 240(1): 111-118, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37494889
6.
Do people with eczema and their carers understand topical steroid potency? Results of two surveys.
Clin Exp Dermatol
; 49(3): 267-270, 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37925627
7.
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial).
J Eur Acad Dermatol Venereol
; 38(5): 864-872, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38179809
8.
Outcomes for Psoriasis by Self-Identified Racial Groups in Ixekizumab Clinical Trials: A Pooled Analysis.
J Drugs Dermatol
; 23(2): 17-22, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38306141
9.
The Pediatric Dermatologist's View of Pediatric Vitiligo.
J Drugs Dermatol
; 23(2): e77-e78, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38306136
10.
The management of Chronic Hand Eczema: A retrospective patient record review.
Contact Dermatitis
; 90(4): 365-371, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38164049
11.
Unveiling the potential: Enhancing caregiver knowledge through video education to address topical corticosteroid concerns in children with eczematous dermatitis.
Pediatr Dermatol
; 41(2): 221-228, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38126606
12.
Non-Systemic Medication for the Treatment of Prurigo Nodularis: A Systematic Review.
J Cutan Med Surg
; 28(2): 173-177, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38291823
13.
755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
Lasers Med Sci
; 39(1): 113, 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38656631
14.
Detection of significant liver fibrosis in Chinese psoriasis patients receiving methotrexate: a comparison between transient elastography and liver histology.
Hong Kong Med J
; 30(2): 110-119, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38651202
15.
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
J Allergy Clin Immunol
; 152(6): 1493-1519, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37678572
16.
A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation.
Int J Mol Sci
; 25(6)2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38542454
17.
S2k guideline: Diagnosis and therapy of localized scleroderma.
J Dtsch Dermatol Ges
; 22(4): 605-620, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38426689
18.
Characteristics of atopic dermatitis patients using complementary and alternative medicine: A literature review.
Ann Dermatol Venereol
; 151(1): 103257, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38489869
19.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol
; 189(4): 392-399, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37279795
20.
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS).
Br J Dermatol
; 189(1): 23-32, 2023 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36999560